SCOLR Pharma, Inc. (AMEX: DDD), a specialty pharmaceutical company, focuses on developing and liscensing Controlled Delivery Technology (CDT®). This technology platform contains multiple patented oral drug delivery technologies for prescription, OTC and nutritional compounds. Through alliances with pharmaceutical and natural products industry companies, SCOLR co-develops new products and adds value as well as protection to existing product franchises. For further information, visit the Company’s web site at www.scolr.com.
- 17 years ago
QualityStocks
SCOLR Pharma, Inc. (AMEX: DDD)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) to Present at ICR Conference 2026
Datavault AI (NASDAQ: DVLT), a leader in AI-driven data valuation, data monetization, credentialing, and digital engagement…
-
QualityStocksNewsBreaks – Beeline Holdings Inc. (NASDAQ: BLNE) Bringing the Power of AI to Home Lending
Beeline Holdings (NASDAQ: BLNE) was featured in a recent article that discussed expansion of its AI-Driven…
-
QualityStocksNewsBreaks – Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Positioning as Vital Player in Critical Mineral Supply Chain
Disseminated on behalf of Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) and may include paid advertising.…